Madryn Asset Management, LP
10% 持股人
Madryn Asset Management, LP is a New York-based alternative asset management firm founded in 2017, specializing in investments in innovative healthcare companies across biopharma, medtech, diagnostics, life sciences, and healthcare IT sectors.[[1]](https://madrynlp.com/about/)[[2]](https://madrynlp.com)[[5]](https://www.privateequityinternational.com/institution-profiles/madryn-asset-management.html) The firm provides flexible, customized financing solutions to support growth and innovation, drawing on extensive experience in investment management and healthcare to generate strong risk-adjusted returns for its limited partners while incorporating ESG considerations as a signatory to the UN Principles for Responsible Investing.[[1]](https://madrynlp.com/about/)[[2]](https://madrynlp.com)
With offices at 330 Madison Avenue in New York and a portfolio value of approximately $36 million across five holdings, including significant positions in Standard BioTools Inc. (SLGC), Establishment Labs Holdings Inc. (ESTA), and Venus Concept Inc. (VERO), Madryn recently reported owning 91% of VERO as of January 15, 2026, per 13D/G filings.[[3]](https://fintel.io/i/madryn-asset-management)[[5]](https://www.privateequityinternational.com/institution-profiles/madryn-asset-management.html) Leadership includes Managing Partner Dr. Avinash Amin, Managing Director Alexander Marcantonio, Principal Addison Wright, and Vice President Austin Ferrone.[[5]](https://www.privateequityinternational.com/institution-profiles/madryn-asset-management.html) The firm manages closed funds such as Madryn Health Partners II and has been involved in funding rounds like the $2.5 million debt for Greenbrook TMS.[[4]](https://www.zoominfo.com/c/madryn-asset-management-lp/435742747)[[5]](https://www.privateequityinternational.com/institution-profiles/madryn-asset-management.html)
查看完整内部人档案 →